QA: Barinthus Biotherapeutics plc in us_pharma/2024

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001828185_2025_Barinthus_Biotherapeutics_plc.pdf

Logs

warning The stock price does not exist industry.us_generic {}

Graph

Absolute values for 0001828185, Barinthus Biotherapeutics plc

  xvar xval
0 AssetsCurrent 125,742,000
1 IntangibleAssetsNetIncludingGoodwill 21,947,000
2 PropertyPlantAndEquipmentNet 7,373,000
3 remainder_Assets 5,265,000
4 LiabilitiesCurrent 15,657,000
5 LiabilitiesNoncurrent 11,447,000
6 remainder_Liabilities 3,088,000
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 29,670,000
9 ResearchAndDevelopmentExpense 42,236,000
10 remainder_Expenses 12,165,000
11 remainder_Revenues 16,145,000
12 remainder_NetIncome 6,743,000
13 remainder_ComprehensiveNetIncome -2,444,000
  yvar yval
0 Assets 160,327,000
1 Liabilities 30,192,000
2 Expenses 84,071,000
3 Revenues 16,145,000
4 StockholdersEquity 130,135,000
5 NetIncome -61,183,000
6 ComprehensiveNetIncome -62,405,000
7 BaseVar 149,961,000
8 EconomicCapitalRatiobeforeLimitedLiability 2.32
9 EconomicCapitalRatio 3.24

Edgar->Model Mapping

Feature Distribution

Change over Time